Business
AmpliTech Group, Inc. Receives Developmental Order for Cryogenic Device to Accelerate Design of New Drugs for Diseases and Materials for Quantum Computers
BOHEMIA, N.Y., April 13, 2021 /PRNewswire/ -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the "Company"), a designer, developer, and manufacturer of custom
About this update from Amplitech Group, Inc.
[{"type":"text","content":"BOHEMIA, N.Y., April 13, 2021 /PRNewswire/ -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the \"Company\"), a designer, developer, and manufacturer of custom and standard state-of-the-art RF components for Commercial, SATCOM, 5G, Quantum Computing, Space, Defense, and Military markets, announced today it received a developmental order from Amplify My Probe, Ltd, for a special cryogenic probe head used to facilitate the study of materials, molecules, and drugs for the treatment of diseases, among many other applications. \nAmpliTech developing cryogenic device to accelerate design of new drugs and materials for Quantum Computers. The probe uses AmpliTech's innovative cryogenic low noise amplifier technology operating at 5 degrees Kelvin (-450 degrees F) physical temperature. These amplifiers have a uniquely low power dissipation and are also used in quantum computing, nanophysics, and astronomy applications.\nDr. Simenas Mantas, a designer on the Amplify My Probe, Ltd team that designed the EPR Cryoprobe stated, \"The device allows the measurements of the Electron Paramagnetic Resonance (EPR) experiments to be done much faster by amplifying microwave signals and suppressing source noise. We anticipate close to 100x speedup of the experiments. Such an improvement is highly relevant in the field as it will significantly expand the domain of systems that can be studied by EPR. Among such systems are biomolecules, catalytic surfaces, materials for quantum computing and others.\"\nAmong many other possible applications, the studying of such systems has the potential to speed up the design of new drugs (for example, to treat Alzheimer's disease), increase efficiency of catalytic processes in chemical industry, and discover new materials for future quantum computers. \nAmpliTech Group, Inc. will be the exclusive manufacturer for this product and Amplify My Probe will be its sole global distributor for a term of at least 18 months. \nCEO Fawad Maqbool, stated, \"We are pleased to work with the Amplify My Probe team to help develop this innovative new product that will advance materials science and medical technology. AmpliTech Group, Inc. is dedicated to be a driving force and leader in amplifier technology for communications and microwave applications that are part of everyday life around us.\" \nAbout AmpliTech Group, Inc.\nAmpliTech ...